USD 45.73
(-5.61%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | 15.26 Million USD | -5.55% |
2023 | 16.16 Million USD | 27.52% |
2022 | 12.67 Million USD | 50.27% |
2021 | 8.43 Million USD | 2.42% |
2020 | 8.23 Million USD | 32.04% |
2019 | 6.23 Million USD | 42.02% |
2018 | 4.39 Million USD | 42.4% |
2017 | 3.08 Million USD | -13.66% |
2016 | 3.57 Million USD | -17.1% |
2015 | 4.31 Million USD | 65.77% |
2014 | 2.6 Million USD | -32.19% |
2013 | 3.83 Million USD | 37.37% |
2012 | 2.79 Million USD | -24.63% |
2011 | 3.7 Million USD | 14.71% |
2010 | 3.22 Million USD | -4.07% |
2009 | 3.36 Million USD | -34.03% |
2008 | 5.1 Million USD | 10.36% |
2007 | 4.62 Million USD | 16.13% |
2006 | 3.98 Million USD | 26.55% |
2005 | 3.14 Million USD | 23.72% |
2004 | 2.54 Million USD | -10.34% |
2003 | 2.83 Million USD | -3.04% |
2002 | 2.92 Million USD | -2.76% |
2001 | 3 Million USD | -29.18% |
2000 | 4.24 Million USD | -9.64% |
1999 | 4.69 Million USD | 5.55% |
1998 | 4.45 Million USD | 6.0% |
1997 | 4.2 Million USD | -10.64% |
1996 | 4.7 Million USD | 487.5% |
1995 | 800 Thousand USD | 0.0% |
1994 | 800 Thousand USD | 60.0% |
1993 | 500 Thousand USD | 66.67% |
1992 | 300 Thousand USD | -25.0% |
1991 | 400 Thousand USD | 33.33% |
1990 | 300 Thousand USD | 50.0% |
1989 | 200 Thousand USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q3 | 14.24 Million USD | -5.22% |
2024 Q2 | 15.02 Million USD | -7.61% |
2024 Q1 | 16.26 Million USD | 0.6% |
2024 Q4 | 15.26 Million USD | 7.21% |
2024 FY | 15.26 Million USD | -5.55% |
2023 Q4 | 16.16 Million USD | 6.75% |
2023 Q3 | 15.14 Million USD | 0.07% |
2023 Q2 | 15.13 Million USD | -3.38% |
2023 Q1 | 15.66 Million USD | 23.55% |
2023 FY | 16.16 Million USD | 27.52% |
2022 Q2 | 9.28 Million USD | 4.24% |
2022 Q4 | 12.67 Million USD | 6.84% |
2022 FY | 12.67 Million USD | 50.27% |
2022 Q1 | 8.9 Million USD | 5.57% |
2022 Q3 | 11.86 Million USD | 27.8% |
2021 Q2 | 9.15 Million USD | 10.09% |
2021 Q1 | 8.31 Million USD | 0.91% |
2021 FY | 8.43 Million USD | 2.42% |
2021 Q4 | 8.43 Million USD | 0.82% |
2021 Q3 | 8.36 Million USD | -8.57% |
2020 Q1 | 6.84 Million USD | 9.7% |
2020 Q2 | 7.8 Million USD | 14.09% |
2020 Q3 | 8.64 Million USD | 10.69% |
2020 Q4 | 8.23 Million USD | -4.69% |
2020 FY | 8.23 Million USD | 32.04% |
2019 Q3 | 4.8 Million USD | 5.84% |
2019 FY | 6.23 Million USD | 42.02% |
2019 Q4 | 6.23 Million USD | 29.84% |
2019 Q2 | 4.54 Million USD | -0.55% |
2019 Q1 | 4.56 Million USD | 3.92% |
2018 Q3 | 3.38 Million USD | 5.82% |
2018 Q1 | 3.51 Million USD | 13.84% |
2018 FY | 4.39 Million USD | 42.4% |
2018 Q4 | 4.39 Million USD | 29.89% |
2018 Q2 | 3.19 Million USD | -9.0% |
2017 Q4 | 3.08 Million USD | 3.7% |
2017 FY | 3.08 Million USD | -13.66% |
2017 Q1 | 3.37 Million USD | -5.68% |
2017 Q2 | 3.27 Million USD | -2.91% |
2017 Q3 | 2.97 Million USD | -9.08% |
2016 FY | 3.57 Million USD | -17.1% |
2016 Q3 | 4.11 Million USD | -8.1% |
2016 Q2 | 4.48 Million USD | 5.41% |
2016 Q4 | 3.57 Million USD | -13.23% |
2016 Q1 | 4.25 Million USD | -1.37% |
2015 Q4 | 4.31 Million USD | 25.15% |
2015 FY | 4.31 Million USD | 65.77% |
2015 Q1 | 2.58 Million USD | -0.5% |
2015 Q3 | 3.44 Million USD | 19.58% |
2015 Q2 | 2.88 Million USD | 11.33% |
2014 Q3 | 3.18 Million USD | -10.36% |
2014 Q2 | 3.55 Million USD | -10.6% |
2014 FY | 2.6 Million USD | -32.19% |
2014 Q4 | 2.6 Million USD | -18.34% |
2014 Q1 | 3.97 Million USD | 3.63% |
2013 Q2 | 3.51 Million USD | 0.95% |
2013 Q4 | 3.83 Million USD | 2.35% |
2013 FY | 3.83 Million USD | 37.37% |
2013 Q1 | 3.48 Million USD | 24.76% |
2013 Q3 | 3.74 Million USD | 6.57% |
2012 Q2 | 4.73 Million USD | 17.12% |
2012 Q3 | 3.05 Million USD | -35.37% |
2012 Q4 | 2.79 Million USD | -8.76% |
2012 FY | 2.79 Million USD | -24.63% |
2012 Q1 | 4.04 Million USD | 9.13% |
2011 Q4 | 3.7 Million USD | 8.37% |
2011 Q2 | 3.9 Million USD | 1.45% |
2011 Q1 | 3.85 Million USD | 19.27% |
2011 FY | 3.7 Million USD | 14.71% |
2011 Q3 | 3.41 Million USD | -12.52% |
2010 Q3 | 2.85 Million USD | -11.19% |
2010 Q2 | 3.21 Million USD | -8.95% |
2010 Q1 | 3.53 Million USD | 4.96% |
2010 FY | 3.22 Million USD | -4.07% |
2010 Q4 | 3.22 Million USD | 13.03% |
2009 Q3 | 3.75 Million USD | -6.29% |
2009 Q2 | 4 Million USD | -13.66% |
2009 Q1 | 4.64 Million USD | -9.04% |
2009 FY | 3.36 Million USD | -34.03% |
2009 Q4 | 3.36 Million USD | -10.36% |
2008 Q2 | 5 Million USD | 12.92% |
2008 FY | 5.1 Million USD | 10.36% |
2008 Q4 | 5.1 Million USD | 8.23% |
2008 Q1 | 4.43 Million USD | -4.07% |
2008 Q3 | 4.71 Million USD | -5.87% |
2007 Q4 | 4.62 Million USD | -2.39% |
2007 FY | 4.62 Million USD | 16.13% |
2007 Q3 | 4.73 Million USD | -0.17% |
2007 Q2 | 4.74 Million USD | 10.02% |
2007 Q1 | 4.31 Million USD | 8.32% |
2006 Q1 | 3.31 Million USD | 5.47% |
2006 Q2 | 3.57 Million USD | 7.78% |
2006 FY | 3.98 Million USD | 26.55% |
2006 Q4 | 3.98 Million USD | -13.53% |
2006 Q3 | 4.6 Million USD | 28.76% |
2005 Q3 | 2.95 Million USD | -0.81% |
2005 FY | 3.14 Million USD | 23.72% |
2005 Q2 | 2.97 Million USD | 3.15% |
2005 Q1 | 2.88 Million USD | 13.49% |
2005 Q4 | 3.14 Million USD | 6.54% |
2004 Q1 | 3.06 Million USD | 8.18% |
2004 Q2 | 2.92 Million USD | -4.63% |
2004 Q3 | 2.6 Million USD | -11.08% |
2004 Q4 | 2.54 Million USD | -2.27% |
2004 FY | 2.54 Million USD | -10.34% |
2003 FY | 2.83 Million USD | -3.04% |
2003 Q4 | 2.83 Million USD | -3.67% |
2003 Q3 | 2.94 Million USD | 14.25% |
2003 Q2 | 2.57 Million USD | -5.12% |
2003 Q1 | 2.71 Million USD | -7.15% |
2002 Q1 | 2.91 Million USD | -2.93% |
2002 Q2 | 3.21 Million USD | 10.04% |
2002 Q3 | 3.33 Million USD | 3.67% |
2002 Q4 | 2.92 Million USD | -12.19% |
2002 FY | 2.92 Million USD | -2.76% |
2001 Q2 | 4.88 Million USD | -0.69% |
2001 FY | 3 Million USD | -29.18% |
2001 Q3 | 4.6 Million USD | -5.82% |
2001 Q4 | 3 Million USD | -34.69% |
2001 Q1 | 4.92 Million USD | 15.93% |
2000 Q2 | 4.9 Million USD | 0.0% |
2000 Q3 | 4.52 Million USD | -7.76% |
2000 Q1 | 4.9 Million USD | 4.28% |
2000 FY | 4.24 Million USD | -9.64% |
2000 Q4 | 4.24 Million USD | -6.06% |
1999 Q4 | 4.69 Million USD | -14.56% |
1999 FY | 4.69 Million USD | 5.55% |
1999 Q1 | 4.6 Million USD | 3.33% |
1999 Q2 | 4.9 Million USD | 6.52% |
1999 Q3 | 5.5 Million USD | 12.24% |
1998 Q3 | 4.4 Million USD | 10.0% |
1998 Q4 | 4.45 Million USD | 1.18% |
1998 Q2 | 4 Million USD | -2.44% |
1998 Q1 | 4.1 Million USD | -2.38% |
1998 FY | 4.45 Million USD | 6.0% |
1997 Q2 | 5.1 Million USD | 6.25% |
1997 Q4 | 4.2 Million USD | -14.29% |
1997 Q3 | 4.9 Million USD | -3.92% |
1997 FY | 4.2 Million USD | -10.64% |
1997 Q1 | 4.8 Million USD | 2.13% |
1996 FY | 4.7 Million USD | 487.5% |
1996 Q3 | 4.9 Million USD | 19.51% |
1996 Q1 | 4.2 Million USD | 425.0% |
1996 Q2 | 4.1 Million USD | -2.38% |
1996 Q4 | 4.7 Million USD | -4.08% |
1995 Q2 | 700 Thousand USD | -12.5% |
1995 Q3 | 800 Thousand USD | 14.29% |
1995 Q4 | 800 Thousand USD | 0.0% |
1995 FY | 800 Thousand USD | 0.0% |
1995 Q1 | 800 Thousand USD | 0.0% |
1994 Q3 | 700 Thousand USD | 40.0% |
1994 Q4 | 800 Thousand USD | 14.29% |
1994 Q2 | 500 Thousand USD | 0.0% |
1994 FY | 800 Thousand USD | 60.0% |
1994 Q1 | 500 Thousand USD | 0.0% |
1993 FY | 500 Thousand USD | 66.67% |
1993 Q4 | 500 Thousand USD | -28.57% |
1993 Q3 | 700 Thousand USD | 0.0% |
1993 Q2 | 700 Thousand USD | 0.0% |
1993 Q1 | 700 Thousand USD | 133.33% |
1992 FY | 300 Thousand USD | -25.0% |
1992 Q3 | 700 Thousand USD | 0.0% |
1992 Q4 | 300 Thousand USD | -57.14% |
1991 Q4 | 400 Thousand USD | 0.0% |
1991 FY | 400 Thousand USD | 33.33% |
1990 Q4 | 300 Thousand USD | 0.0% |
1990 FY | 300 Thousand USD | 50.0% |
1989 FY | 200 Thousand USD | 0.0% |
1989 Q4 | 200 Thousand USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Akoya Biosciences, Inc. | 17.87 Million USD | 14.589% |
AngioDynamics, Inc. | 60.61 Million USD | 74.81% |
AtriCure, Inc. | 67.89 Million USD | 77.512% |
Avinger, Inc. | 5.29 Million USD | -188.203% |
Azenta, Inc. | 128.19 Million USD | 88.09% |
BioLife Solutions, Inc. | 43.45 Million USD | 64.863% |
The Cooper Companies, Inc. | 735.6 Million USD | 97.924% |
Daxor Corporation | - USD | -Infinity% |
Ekso Bionics Holdings, Inc. | 5.05 Million USD | -202.356% |
Femasys Inc. | 667.11 Thousand USD | -2188.8% |
GlucoTrack, Inc. | - USD | -Infinity% |
Harvard Bioscience, Inc. | 24.71 Million USD | 38.222% |
Hologic, Inc. | 679.8 Million USD | 97.754% |
ICU Medical, Inc. | 709.36 Million USD | 97.847% |
Intuitive Surgical, Inc. | 1.22 Billion USD | 98.749% |
KORU Medical Systems, Inc. | 3.48 Million USD | -338.6% |
LeMaitre Vascular, Inc. | 52.33 Million USD | 70.823% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | -1682.181% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | -1682.181% |
Masimo Corporation | 545 Million USD | 97.198% |
Microbot Medical Inc. | - USD | -Infinity% |
Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -844.148% |
Merit Medical Systems, Inc. | 303.87 Million USD | 94.975% |
Nephros, Inc. | 2.47 Million USD | -518.178% |
NovoCure Limited | 38.15 Million USD | 59.979% |
NEXGEL, Inc. | 1.31 Million USD | -1057.619% |
NEXGEL, Inc. | 1.31 Million USD | -1057.619% |
Singular Genomics Systems, Inc. | 13.57 Million USD | -12.504% |
OraSure Technologies, Inc. | 47.61 Million USD | 67.932% |
Pulse Biosciences, Inc. | - USD | -Infinity% |
Predictive Oncology Inc. | 494.37 Thousand USD | -2988.552% |
Precision Optics Corporation, Inc. | 2.86 Million USD | -432.373% |
QuidelOrtho Corporation | 577.8 Million USD | 97.357% |
Repligen Corporation | 202.32 Million USD | 92.453% |
Sanara MedTech Inc. | 4.71 Million USD | -223.665% |
STAAR Surgical Company | 35.13 Million USD | 56.536% |
Sharps Technology, Inc. | 1.7 Million USD | -793.376% |
Utah Medical Products, Inc. | 9.58 Million USD | -59.351% |
DENTSPLY SIRONA Inc. | 624 Million USD | 97.553% |
Jin Medical International Ltd. | 5.05 Million USD | -202.169% |